ID24596A - Mikrosfer-mikrosfer farmasi yang mengandung asam valproat untuk pemakaian oral - Google Patents

Mikrosfer-mikrosfer farmasi yang mengandung asam valproat untuk pemakaian oral

Info

Publication number
ID24596A
ID24596A IDW990095D ID990095D ID24596A ID 24596 A ID24596 A ID 24596A ID W990095 D IDW990095 D ID W990095D ID 990095 D ID990095 D ID 990095D ID 24596 A ID24596 A ID 24596A
Authority
ID
Indonesia
Prior art keywords
valproat
contain
acid
oral usage
pharmaceutical microsphere
Prior art date
Application number
IDW990095D
Other languages
English (en)
Inventor
Christian Langlois
Jean-Yves Lanner
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of ID24596A publication Critical patent/ID24596A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IDW990095D 1996-10-07 1997-10-03 Mikrosfer-mikrosfer farmasi yang mengandung asam valproat untuk pemakaian oral ID24596A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9612201A FR2754177B1 (fr) 1996-10-07 1996-10-07 Microspheres pharmaceutiques d'acide valproique pour administration orale

Publications (1)

Publication Number Publication Date
ID24596A true ID24596A (id) 2000-07-27

Family

ID=9496427

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW990095D ID24596A (id) 1996-10-07 1997-10-03 Mikrosfer-mikrosfer farmasi yang mengandung asam valproat untuk pemakaian oral

Country Status (40)

Country Link
US (3) US20020001598A1 (id)
EP (1) EP0956010B1 (id)
JP (1) JP3523270B2 (id)
KR (1) KR100334687B1 (id)
CN (1) CN100367945C (id)
AR (1) AR013613A1 (id)
AT (1) ATE216228T1 (id)
AU (1) AU731235B2 (id)
BR (1) BR9712268A (id)
CA (1) CA2267096C (id)
CO (1) CO4900080A1 (id)
CZ (1) CZ288876B6 (id)
DE (1) DE69712100T2 (id)
DK (1) DK0956010T3 (id)
DZ (1) DZ2316A1 (id)
EE (1) EE03744B1 (id)
EG (1) EG24070A (id)
ES (1) ES2174293T3 (id)
FR (1) FR2754177B1 (id)
HK (1) HK1021939A1 (id)
HR (1) HRP970537B1 (id)
HU (1) HU225103B1 (id)
ID (1) ID24596A (id)
IL (1) IL128745A (id)
IS (1) IS1985B (id)
ME (1) ME00664B (id)
MY (1) MY120521A (id)
NO (1) NO325723B1 (id)
NZ (1) NZ334399A (id)
PL (1) PL190105B1 (id)
PT (1) PT956010E (id)
RS (1) RS49602B (id)
RU (1) RU2177315C2 (id)
SI (1) SI0956010T1 (id)
SK (1) SK282113B6 (id)
TR (1) TR199900789T2 (id)
TW (1) TW508251B (id)
UY (1) UY24738A1 (id)
WO (1) WO1998015268A1 (id)
ZA (1) ZA978954B (id)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA01012659A (es) 1999-06-07 2003-09-04 Altana Pharma Ag Nueva forma de administracion y preparacion que comprende un compuesto activo labil acido.
US20060223888A1 (en) * 2002-12-16 2006-10-05 Abbott Frank S Valproic acid analogues and pharmaceutical composition thereof
TWI356036B (en) * 2004-06-09 2012-01-11 Smithkline Beecham Corp Apparatus and method for pharmaceutical production
CA2579576A1 (en) * 2004-09-07 2006-03-16 Orphan Medical, Inc. Improved ghb compositions
US9149433B2 (en) * 2004-11-30 2015-10-06 Basf Corporation Method for formation of micro-prilled polymers
US20060252830A1 (en) * 2005-05-06 2006-11-09 Brandon Stephen F Method for the treatment of magnesium and potassium deficiencies
US20060252831A1 (en) * 2005-05-06 2006-11-09 Christopher Offen Method for the treatment of magnesium and potassium deficiencies
US8992422B2 (en) 2006-03-23 2015-03-31 Ethicon Endo-Surgery, Inc. Robotically-controlled endoscopic accessory channel
CN101543631B (zh) * 2008-03-28 2012-01-11 沈阳兴齐制药有限公司 含蜂蜡的微球基质、含有它的药物组合物及其用途
US8952060B2 (en) * 2009-05-12 2015-02-10 Amorepacific Corporation Composition for preventing hair loss or for stimulating hair growth
TN2016000160A1 (en) * 2013-11-13 2017-10-06 Tillotts Pharma Ag Multi-particulate drug delivery system.
CN104013596A (zh) * 2014-05-16 2014-09-03 安士制药（中山）有限公司 一种丙戊酸软胶囊及其制备方法
CN105456217A (zh) * 2014-08-27 2016-04-06 捷思英达医药技术（上海）有限公司 一种双丙戊酸钠缓释剂组合物及其制备方法
JPWO2019039345A1 (ja) 2017-08-24 2020-03-26 三井化学株式会社 リチウム二次電池及び非水電解液
JPWO2019039346A1 (ja) 2017-08-24 2020-03-26 三井化学株式会社 電池用非水電解液及びリチウム二次電池
FR3087445B1 (fr) * 2018-10-19 2021-12-17 Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic Composition lipidique pour l'encapsulation d'une substance active et permettant le controle de la vitesse de liberation de ladite substance active
CN111012753A (zh) * 2020-01-07 2020-04-17 仁和堂药业有限公司 一种提高丙戊酸钠片剂稳定性的方法
CN112274499A (zh) * 2020-11-16 2021-01-29 仁和堂药业有限公司 一种提高丙戊酸钠片剂稳定性的方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2293974A1 (fr) * 1973-03-02 1976-07-09 Kaltenbach Roger Procede et dispositif pour la granulation reguliere de divers produits
US5212326A (en) * 1979-08-20 1993-05-18 Abbott Laboratories Sodium hydrogen divalproate oligomer
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
US5185159A (en) * 1983-07-20 1993-02-09 Sanofi Pharmaceutical composition based on valproic acid and a process for preparing it
IL72381A (en) * 1983-07-20 1988-03-31 Sanofi Sa Pharmaceutical composition based on valproic acid
US4913906B1 (en) * 1985-02-28 2000-06-06 Yissum Res Dev Co Controlled release dosage form of valproic acid
JP2893191B2 (ja) * 1988-11-08 1999-05-17 武田薬品工業株式会社 放出制御性マトリックス剤
EP0418596A3 (en) * 1989-09-21 1991-10-23 American Cyanamid Company Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
FR2657257B1 (fr) * 1990-01-19 1994-09-02 Rhone Poulenc Sante Procede de preparation de medicaments sous forme de perles.
TW209174B (id) * 1991-04-19 1993-07-11 Takeda Pharm Industry Co Ltd
JP3426230B2 (ja) * 1991-05-20 2003-07-14 アベンティス・ファーマスーティカルズ・インコーポレイテッド 複数層の制御放出処方剤
FR2682677A1 (fr) * 1991-10-17 1993-04-23 Sanofi Elf Complexe forme de l'acide propyl-2 pentene-2 ouique (e) et de son sel de sodium, sa preparation et compositions pharmaceutiques le contenant.
US6287598B1 (en) * 1993-05-28 2001-09-11 Alza Corporation Method for providing sustained antiepileptic therapy
US5690959A (en) * 1993-05-29 1997-11-25 Smithkline Beecham Corporation Pharmaceutical thermal infusion process
AUPN969796A0 (en) * 1996-05-07 1996-05-30 F.H. Faulding & Co. Limited Taste masked liquid suspensions
US5916910A (en) * 1997-06-04 1999-06-29 Medinox, Inc. Conjugates of dithiocarbamates with pharmacologically active agents and uses therefore
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
UA80393C2 (uk) * 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці

Also Published As

Publication number Publication date
IS1985B (is) 2005-02-15
EP0956010A1 (fr) 1999-11-17
DE69712100D1 (de) 2002-05-23
FR2754177A1 (fr) 1998-04-10
CN1232391A (zh) 1999-10-20
EG24070A (en) 2008-05-11
RU2177315C2 (ru) 2001-12-27
DE69712100T2 (de) 2002-11-28
CA2267096C (fr) 2003-09-16
US20060263437A1 (en) 2006-11-23
EP0956010B1 (fr) 2002-04-17
PT956010E (pt) 2002-08-30
TR199900789T2 (xx) 1999-07-21
SI0956010T1 (en) 2002-10-31
KR20000048828A (ko) 2000-07-25
HUP9903855A2 (hu) 2000-05-28
CZ288876B6 (cs) 2001-09-12
TW508251B (en) 2002-11-01
JP2000504038A (ja) 2000-04-04
US20030157177A1 (en) 2003-08-21
IL128745A0 (en) 2000-01-31
AU731235B2 (en) 2001-03-29
SK36499A3 (en) 2000-12-11
US8535721B2 (en) 2013-09-17
HK1021939A1 (en) 2000-07-21
CZ121199A3 (cs) 1999-08-11
AU4560297A (en) 1998-05-05
SK282113B6 (sk) 2001-11-06
FR2754177B1 (fr) 1999-08-06
JP3523270B2 (ja) 2004-04-26
EE9900140A (et) 1999-12-15
HU225103B1 (en) 2006-06-28
HUP9903855A3 (en) 2000-06-28
NO325723B1 (no) 2008-07-07
YU17899A (sh) 2000-03-21
US20020001598A1 (en) 2002-01-03
KR100334687B1 (ko) 2002-04-27
BR9712268A (pt) 1999-08-31
DZ2316A1 (fr) 2002-12-28
ES2174293T3 (es) 2002-11-01
CN100367945C (zh) 2008-02-13
RS49602B (sr) 2007-06-04
EE03744B1 (et) 2002-06-17
ME00664B (me) 2007-06-04
UY24738A1 (es) 2001-05-31
IL128745A (en) 2004-05-12
HRP970537B1 (en) 2002-08-31
CO4900080A1 (es) 2000-03-27
IS4996A (is) 1999-03-11
HRP970537A2 (en) 1998-08-31
AR013613A1 (es) 2001-01-10
ATE216228T1 (de) 2002-05-15
ZA978954B (en) 1999-04-07
WO1998015268A1 (fr) 1998-04-16
MY120521A (en) 2005-11-30
NZ334399A (en) 2000-05-26
NO991613L (no) 1999-04-06
CA2267096A1 (fr) 1998-04-16
PL332249A1 (en) 1999-08-30
DK0956010T3 (da) 2002-08-12
PL190105B1 (pl) 2005-10-31
NO991613D0 (no) 1999-04-06

Similar Documents

Publication Publication Date Title
ID24596A (id) Mikrosfer-mikrosfer farmasi yang mengandung asam valproat untuk pemakaian oral
DK0936913T4 (da) Oralt farmaceutisk præparat indeholdende ibandronat
ID24654A (id) Formulasi farmasi omeprazola
AU7375598A (en) Stable oral pharmaceutical dosage forms
HK1041224A1 (zh) 新的藥物製劑
ID22939A (id) Formulasi-formulasi farmasi yang mengandung vorikonozal
ID24376A (id) Turunan-turunan asam amidokarboksilat
DE69924999D1 (de) Lipasehemmer enthaltende pharmazeutische zusammensetzungen
ID23299A (id) Formulasi-formulasi farmasi
ID26334A (id) Morfolinol yang aktif secara farmasi
ID20807A (id) Asam sulfonilaminokarboksilat
NO995251D0 (no) FremgangsmÕte for administrering av haloterapi
DE69822172D1 (de) Levosimendanhaltige oral anzuwendende arzneizusammensetzungen
PT868911E (pt) Formulacoes de rapamicina para administracao oral
ID17875A (id) Komposisi farmasi yang mengandung asam 4-oksobutanoat
EE9800400A (et) Diklofenaaki sisaldavad farmatseutilised kompositsioonid
ID16781A (id) Formulasi-formulasi farmasi
ATE295150T1 (de) Pharmazeutische zusammensetzungen
ID20685A (id) Sediaan-sediaan farmasi silansetron yang distabilkan terhadap rasemisasi
ATE283687T1 (de) Rapamycin-formulierungen zur oralen verabreichung
ID17326A (id) Turunan-turunan asam 4-arilbutirat tersubstitusi sebagai inhibitor-inhibitor matriks metalloprotease
NO981320D0 (no) Oral anvendelse av (+)-O-demetyltramadol som smertemiddel
ID19162A (id) Komposisi farmasi yang mengandung trehalosa
NO20003284L (no) Farmasøytisk preparat for oral administrering
BR1101183A (pt) formulações contendo ácido hialurÈnico